XTL Biopharmaceuticals Ltd ADR
Price & Volume
Stats
See more52W Range | $0.53-$2.56 |
Market Cap | $7.6M |
Shares Short | 65,629 |
Financials
See moreRevenue (12 Mos) | $968,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$2.2M |
Diluted EPS | -$0.90 |
News
See moreYahoo Finance • 2 months ago
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
Yahoo Finance • 7 months ago
XTL Biopharmaceuticals shareholders approve board elections and private placement
Yahoo Finance • 8 months ago
XTL Biopharmaceuticals postpones shareholder meeting due to lack of quorum
Yahoo Finance • 11 months ago
XTL Names Mr. Noam Band as its New Chief Executive Officer
About
CEO | Mr. Noam Band |
Address | 26 Ben-Gurion St., Ramat Gan, Israel, 5112001 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 10 |
